Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer.
Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
- IRB Number: 1902624997 (RADY-ECOG-ACRIN-EA8171)
- Research Study Identifier: TX10171
- Principal Investigator: Temel Tirkes, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required